Join
Live feed
·
INSIDERFilingvia Quantisnow
Ironwood Pharmaceuticals Inc. logo

Chief Executive Officer Mccourt Thomas A sold $7,745 worth of shares (13,353 units at $0.58) and was granted 540,000 shares, increasing direct ownership by 45% to 1,687,281 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IRWD (Ironwood Pharmaceuticals Inc.) and more on Quantisnow.